Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ENFN

Enfusion Inc

Jan 14 • 04:00PM ET

10.81

Dollar change 0.00
Percentage change 0.00	%

Technology • Software - Application • USA • NYSE

Peers: BLK JPM MS GS UBS EVR PJT MC CVLT NDAQ

| Held by: IWM VGT VTI VB VXF IWO VBK VTWO SCHA XSW

Scroll to Statements

Index	RUT	P/E	412.60	EPS (ttm)	0.03	Insider Own	47.77%	Shs Outstand	93.26M	Perf Week	3.84%
Market Cap	1.39B	Forward P/E	37.63	EPS next Y	0.29	Insider Trans	-0.17%	Shs Float	49.29M	Perf Month	1.50%
Income	3.34M	PEG	-	EPS next Q	0.06	Inst Own	59.46%	Short Float	1.13%	Perf Quarter	20.24%
Sales	195.16M	P/S	7.12	EPS this Y	62.17%	Inst Trans	0.11%	Short Ratio	1.03	Perf Half Y	22.84%
Book/sh	0.75	P/B	14.42	EPS next Y	36.25%	ROA	2.82%	Short Interest	0.56M	Perf Year	24.11%
Cash/sh	0.38	P/C	28.78	EPS next 5Y	-	ROE	5.54%	52W Range	7.52 - 11.38	Perf YTD	4.95%
Dividend Est.	-	P/FCF	69.77	EPS past 5Y	-10.61%	ROI	3.92%	52W High	-4.97%	Beta	0.94
Dividend TTM	-	Quick Ratio	3.62	Sales past 5Y	31.47%	Gross Margin	67.15%	52W Low	43.75%	ATR (14)	0.44
Dividend Ex-Date	-	Current Ratio	3.62	EPS Y/Y TTM	-45.43%	Oper. Margin	3.44%	RSI (14)	57.54	Volatility	3.73% 4.26%
Employees	1102	Debt/Eq	0.30	Sales Y/Y TTM	15.78%	Profit Margin	1.71%	Recom	3.17	Target Price	11.06
Option/Short	Yes / Yes	LT Debt/Eq	0.22	EPS Q/Q	-23.08%	Payout	0.00%	Rel Volume	4.91	Prev Close	10.81
Sales Surprise	-1.92%	EPS Surprise	-12.43%	Sales Q/Q	15.35%	Earnings	Nov 04 BMO	Avg Volume	541.21K	Price	10.81
SMA20	3.38%	SMA50	7.30%	SMA200	17.57%	Trades		Volume	2,655,105	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-10-24	Resumed	Morgan Stanley	Overweight	$11
Feb-28-24	Downgrade	Goldman	Neutral → Sell	$9 → $8
Jan-30-24	Downgrade	JP Morgan	Neutral → Underweight	$11 → $9
Nov-07-23	Initiated	UBS	Neutral	$9
Apr-03-23	Initiated	Piper Sandler	Neutral	$11
Mar-15-23	Initiated	JP Morgan	Neutral	$12
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform	$15 → $10
Jan-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$13 → $12
Oct-03-22	Downgrade	BofA Securities	Buy → Neutral	$17 → $15
Nov-15-21	Initiated	William Blair	Outperform
Nov-15-21	Initiated	Stifel	Buy	$27
Nov-15-21	Initiated	Piper Sandler	Overweight	$26
Nov-15-21	Initiated	Morgan Stanley	Equal-Weight	$24
Nov-15-21	Initiated	Goldman	Neutral	$26
Nov-15-21	Initiated	Credit Suisse	Neutral	$26
Nov-15-21	Initiated	BofA Securities	Buy	$30

Show Previous Ratings

Jan-14-25 02:07PM	MS cuts rating on Enfusion stock after Clearwaters acquisition bid (Investing.com)
09:45AM	Enfusion downgraded to Hold from Buy at Stifel (TipRanks)
Jan-13-25 06:40AM	Clearwater to buy software maker Enfusion for $1.5 billion in expansion push (Reuters) +8.75%
06:30AM	Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities (Business Wire)
Dec-17-24 03:09PM	Fastly Stock Gets IBD Rating Upgrade (Investor's Business Daily)
04:15PM	Loading…
Nov-20-24 04:15PM	Enfusion To Present at Upcoming Investor Events (Business Wire)
Nov-05-24 02:04AM	Enfusion Inc (ENFN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:21AM	Q3 2024 Enfusion Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-04-24 09:30AM	Here's What Key Metrics Tell Us About Enfusion (ENFN) Q3 Earnings (Zacks)
08:45AM	Enfusion, Inc. (ENFN) Q3 Earnings and Revenues Miss Estimates (Zacks)
07:30AM	Enfusion Announces Third Quarter 2024 Results (Business Wire)
Nov-01-24 09:06AM	Enfusion Inc (ENFN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-18-24 03:49AM	Enfusion, Inc. (ENFN): This Fintech Stock Is Riding the AI Wave Higher (Insider Monkey)
Oct-10-24 09:00AM	Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation (Business Wire)
Oct-03-24 08:30AM	Enfusion Announces Date of Third Quarter 2024 Results (Business Wire)
10:06AM	Loading…
Sep-23-24 10:06AM	Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last? (Zacks) +5.79%
Sep-20-24 01:47PM	Exclusive-Financial software maker Enfusion explores options including sale, sources say (Reuters) +5.03%
Sep-09-24 08:36AM	Implied Volatility Surging for Enfusion (ENFN) Stock Options (Zacks)
Aug-30-24 04:08AM	Should You Believe in Enfusions (ENFN) Healthy Revenue Growth And Margin Expansion in the Future? (Insider Monkey)
Aug-07-24 05:09AM	Q2 2024 Enfusion Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 09:30AM	Enfusion (ENFN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -7.86%
08:50AM	Enfusion, Inc. (ENFN) Q2 Earnings and Revenues Miss Estimates (Zacks)
07:30AM	Enfusion Announces Second Quarter 2024 Results (Business Wire)
Aug-02-24 08:45AM	Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility (Business Wire)
Jul-16-24 08:30AM	Enfusion Announces Date of Second Quarter 2024 Results (Business Wire)
Jun-22-24 03:44AM	Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN) (GuruFocus.com)
Jun-12-24 10:18AM	Implied Volatility Surging for Enfusion (ENFN) Stock Options (Zacks)
May-29-24 04:15PM	Enfusion To Present at Upcoming Investor Events (Business Wire)
May-22-24 07:08PM	Insider Sale: Chief People Officer Bronwen Bastone Sells 34,059 Shares of Enfusion Inc (ENFN) (GuruFocus.com)
May-13-24 11:56AM	Enfusion, Inc. (NYSE:ENFN) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:49AM	Loading…
May-09-24 10:49AM	Enfusion Shares Fall Despite Higher Q1 Results (MT Newswires) -5.22%
09:30AM	Enfusion (ENFN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
07:30AM	Enfusion Announces First Quarter 2024 Results (Business Wire)
Apr-18-24 08:30AM	Enfusion Announces Date of First Quarter 2024 Results (Business Wire)
Apr-04-24 07:00AM	The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024 (InvestorPlace)
Apr-02-24 09:07AM	Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future? (Insider Monkey)
Mar-21-24 08:00AM	Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion (Business Wire)
Mar-15-24 06:00AM	Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024 (InvestorPlace)
Mar-14-24 08:20AM	Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 10:53PM	Q4 2023 Enfusion Inc Earnings Call (Thomson Reuters StreetEvents) +9.86%
10:00AM	Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:45AM	Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates (Zacks)
07:30AM	Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results (Business Wire)
Feb-13-24 08:30AM	Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-12-24 08:30AM	Enfusion to Host Investor Day on March 19, 2024 (Business Wire)
Jan-30-24 07:00AM	Kore.ai Secures $150 Million Strategic Growth Investment to Drive AI-powered Customer and Employee Experiences for Global Brands (PR Newswire) -5.53%
Jan-24-24 09:00AM	BillingPlatform Secures $90 Million Growth Equity Investment from FTV Capital (PR Newswire)
Jan-18-24 08:15AM	Enfusion Elevates Valeria Gutowski to Chief Accounting Officer (Business Wire)
Dec-06-23 08:58AM	Hidden Gems: 3 Small-Cap Tech Stocks With Huge Potential (InvestorPlace)
Nov-20-23 08:15AM	Enfusion Announces Appointment of Chief Operating Officer (Business Wire)
Nov-12-23 09:17AM	Enfusion, Inc. (NYSE:ENFN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 09:30AM	Enfusion, Inc. (ENFN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:30AM	Enfusion Announces Third Quarter 2023 Results (Business Wire)
Nov-01-23 10:01AM	Unity Software Inc. (U) Earnings Expected to Grow: Should You Buy? (Zacks) -5.18%
Oct-31-23 10:01AM	Enfusion, Inc. (ENFN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-19-23 08:30AM	Enfusion Announces Date of Third Quarter 2023 Results (Business Wire)
Oct-10-23 09:00AM	Enfusion Launches Portfolio Workbench, Empowering Portfolio Managers to Seamlessly Rebalance Multi-Asset Portfolios (Business Wire)
Sep-19-23 09:17AM	The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023 (InvestorPlace)
Sep-18-23 08:30AM	Enfusion Announces Closing of New $100 Million Credit Facility (Business Wire)
Aug-10-23 06:59AM	Enfusion (NYSE:ENFN) Will Be Hoping To Turn Its Returns On Capital Around (Simply Wall St.)
Aug-08-23 10:00AM	Here's What Key Metrics Tell Us About Enfusion, Inc. (ENFN) Q2 Earnings (Zacks) -12.70%
09:15AM	Enfusion, Inc. (ENFN) Q2 Earnings and Revenues Lag Estimates (Zacks)
07:30AM	Enfusion Announces Second Quarter 2023 Results (Business Wire)
Jul-21-23 01:35PM	Strength Seen in Olo Inc. (OLO): Can Its 6.3% Jump Turn into More Strength? (Zacks)
Jul-19-23 08:30AM	Enfusion Announces Date of Second Quarter 2023 Results (Business Wire)
Jul-13-23 06:18AM	Investing in Enfusion (NYSE:ENFN) a year ago would have delivered you a 19% gain (Simply Wall St.)
Jun-29-23 11:40AM	META vs. ENFN: Which Stock Should Value Investors Buy Now? (Zacks)
Jun-27-23 06:15PM	Enfusion, Inc. (ENFN) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jun-26-23 11:47AM	Exclusive-Software company Enfusion draws takeover interest from private equity, Irenic Capital (Reuters) +19.87%
Jun-14-23 06:15PM	Enfusion, Inc. (ENFN) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jun-01-23 02:11PM	Is The Market Rewarding Enfusion, Inc. (NYSE:ENFN) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? (Simply Wall St.)
May-25-23 08:30AM	Enfusion To Present at the 43rd Annual William Blair Growth Stock Conference (Business Wire)
May-11-23 08:00AM	Bregal Sagemount and FTV Capital Announce Strategic Growth Investment in Neptune Flood Incorporated (PR Newswire)
May-10-23 12:40AM	Q1 2023 Enfusion Inc Earnings Call (Thomson Reuters StreetEvents) -8.22%
May-09-23 08:45AM	Enfusion, Inc. (ENFN) Q1 Earnings Meet Estimates (Zacks)
08:35AM	Enfusion and Granite Construction have been highlighted as Zacks Bull and Bear of the Day (Zacks)
07:30AM	Enfusion Announces First Quarter 2023 Results (Business Wire)
07:09AM	Bull Of The Day: Enfusion (ENFN) (Zacks)
May-08-23 07:20AM	BCE's Q1 Earnings Beat Estimates, Revenues Increase Y/Y (Zacks)
May-05-23 01:57PM	DoorDash (DASH) Reports Q1 Loss, Beats Revenue Estimates (Zacks)
01:46PM	BILL Holdings (BILL) Q3 Earnings Top Estimates, Revenues Up Y/Y (Zacks)
01:41PM	Shopify (SHOP) Q1 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
01:29PM	Microchip (MCHP) Q4 Earnings Top Estimates, Sales Rise Y/Y (Zacks)
01:28PM	Apple (AAPL) Q2 Earnings Beat Estimates, Revenues Decline Y/Y (Zacks)
12:42PM	Fewer Investors Than Expected Jumping On Enfusion, Inc. (NYSE:ENFN) (Simply Wall St.)
12:39PM	Enfusion (ENFN) to Report Q1 Earnings: What's in the Offing? (Zacks)
11:41AM	Datadog (DDOG) Q1 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
08:29AM	Dolby's (DLB) Q2 Earnings & Revenues Beat Estimates, Up Y/Y (Zacks)
07:52AM	TELUS (TU) Q1 Earnings Miss Estimates, Revenues Rise Y/Y (Zacks)
07:48AM	Cirrus Logic (CRUS) Q4 Earnings Top Estimates, Down Y/Y (Zacks)
May-04-23 08:06AM	ANSYS (ANSS) Q1 Earnings & Revenues Beat Estimates, Up Y/Y (Zacks)
08:01AM	Watts Water (WTS) Q1 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
May-03-23 11:50AM	CDW's Q1 Earnings & Revenues Surpass Estimates, Down Y/Y (Zacks)
08:54AM	Lumen (LUMN) Q1 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
May-02-23 06:15PM	Enfusion, Inc. (ENFN) Flat As Market Sinks: What You Should Know (Zacks)
02:05PM	Global SaaS Leader Zone & Co Appoints Seasoned FinTech Exec Thomas Kim as New CEO (PR Newswire)
10:02AM	Enfusion, Inc. (ENFN) Q1 Earnings Preview: What's in the Cards? (Zacks)
Apr-28-23 12:31PM	SNAP's Q1 Earnings Increase Y/Y, Revenues Miss Estimates (Zacks)
Apr-25-23 09:55AM	Bears are Losing Control Over Enfusion, Inc. (ENFN), Here's Why It's a 'Buy' Now (Zacks)
Apr-24-23 06:15PM	Enfusion, Inc. (ENFN) Outpaces Stock Market Gains: What You Should Know (Zacks)

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Somers Deirdre	Director	Jan 13 '25	Proposed Sale	10.53	1,637	17,241		Jan 13 03:16 PM
Movchan Oleg	Chief Executive Officer	Jan 07 '25	Sale	10.13	2,771	28,070	526,702	Jan 10 04:20 PM
Herring Bradley	Chief Financial Officer	Jan 07 '25	Sale	10.13	4,134	41,877	266,369	Jan 10 04:19 PM
Gutowski Valeria	Chief Accounting Officer	Jan 07 '25	Sale	10.13	796	8,063	34,803	Jan 10 04:18 PM
Campobasso Matthew	General Counsel	Jan 07 '25	Sale	10.13	976	9,887	52,651	Jan 10 04:16 PM
Bastone Bronwen	Chief People Officer	Jan 07 '25	Sale	10.13	809	8,195	194,885	Jan 10 04:15 PM
Movchan Oleg	Officer	Jan 07 '25	Proposed Sale	10.13	2,771	28,072		Jan 07 03:44 PM
Bastone Bronwen	Officer	Jan 07 '25	Proposed Sale	10.13	809	8,196		Jan 07 03:43 PM
Herring Bradley	Officer	Jan 07 '25	Proposed Sale	10.13	4,134	41,879		Jan 07 03:40 PM
Campobasso Matthew	Officer	Jan 07 '25	Proposed Sale	10.13	976	9,887		Jan 07 03:40 PM
Herring Bradley	Chief Financial Officer	Dec 20 '24	Sale	10.61	24,443	259,340	270,503	Dec 26 04:15 PM
Herring Bradley	Officer	Dec 20 '24	Proposed Sale	10.61	24,443	259,416		Dec 20 03:57 PM
Pawar Neal	Chief Operating Officer	Dec 03 '24	Sale	10.09	26,246	264,822	1,117,298	Dec 04 04:15 PM
Pawar Neal	Chief Operating Officer	Dec 02 '24	Sale	10.03	21,801	218,664	1,143,544	Dec 04 04:15 PM
Pawar Neal	Officer	Dec 03 '24	Proposed Sale	10.09	26,246	264,814		Dec 03 04:44 PM
Pawar Neal	Chief Operating Officer	Nov 29 '24	Sale	9.92	19,226	190,722	1,165,345	Dec 02 04:52 PM
Pawar Neal	Officer	Dec 02 '24	Proposed Sale	10.03	21,560	216,193		Dec 02 04:21 PM
Pawar Neal	Officer	Nov 29 '24	Proposed Sale	9.92	19,226	190,712		Nov 29 03:33 PM
Campobasso Matthew	General Counsel	Oct 22 '24	Sale	8.95	674	6,032	53,627	Oct 24 04:15 PM
Campobasso Matthew	Officer	Oct 22 '24	Proposed Sale	8.95	674	6,031		Oct 22 03:43 PM
Bastone Bronwen	Chief People Officer	Sep 10 '24	Sale	8.12	3,219	26,138	195,694	Sep 12 04:15 PM
Bastone Bronwen	Officer	Sep 10 '24	Proposed Sale	8.12	3,219	26,153		Sep 10 03:16 PM
Gutowski Valeria	Chief Accounting Officer	Jun 18 '24	Sale	8.17	1,258	10,278	35,599	Jun 21 06:40 PM
Campobasso Matthew	General Counsel	Jun 18 '24	Sale	8.17	1,651	13,489	54,301	Jun 21 06:39 PM
Bastone Bronwen	Chief People Officer	Jun 20 '24	Sale	8.11	18,241	147,935	198,913	Jun 21 06:38 PM
Bastone Bronwen	Chief People Officer	Jun 18 '24	Sale	8.17	10,539	86,104	217,154	Jun 21 06:38 PM
Somers Deirdre	Director	Jun 14 '24	Sale	8.40	4,629	38,884	43,312	Jun 17 09:14 PM
Bastone Bronwen	Chief People Officer	May 20 '24	Sale	9.55	34,059	325,263	227,693	May 22 03:36 PM
Campobasso Matthew	General Counsel	Feb 29 '24	Sale	8.73	108	943	30,840	Mar 04 07:35 PM
Gutowski Valeria	Chief Accounting Officer	Feb 29 '24	Sale	8.73	27	236	17,570	Mar 04 07:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ENFN

Enfusion Inc

Upgrade your FINVIZ experience